SCHEMBL31026348

SCHEMBL31026348

C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NOD1 Q9Y239 1/20 0.54
KMT2A Q03164 2/20 0.43
DPP4 P27487 1/20 0.42
DPP8 Q6V1X1 1/20 0.42
DPP9 Q86TI2 1/20 0.42
FOLH1 Q04609 4/20 0.42
ALOX15 P16050 1/20 0.42
BLM P54132 1/20 0.42
PMP22 Q01453 1/20 0.42
CA2 P00918 4/20 0.41
CA1 P00915 3/20 0.41
ECE1 P42892 2/20 0.40
BMP1 P13497 1/20 0.40
NAALAD2 Q9Y3Q0 2/20 0.40
RIMKLA Q8IXN7 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
BACE1 P56817 1/20 0.38
PRSS1 P07477 2/20 0.38
TMPRSS15 P98073 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4281665 1.00 NOD1 (0.54) NOD1KMT2ADPP4DPP8DPP9
SCHEMBL31376473 1.00 NOD1 (0.54) NOD1KMT2ADPP4DPP8DPP9
SCHEMBL16672263 1.00 NOD1 (0.54) NOD1KMT2ADPP4DPP8DPP9
SCHEMBL1692049 1.00 NOD1 (0.54) NOD1KMT2ADPP4DPP8DPP9
SCHEMBL31026347 1.00 NOD1 (0.54) NOD1KMT2ADPP4DPP8DPP9
SCHEMBL31376471 1.00 NOD1 (0.54) NOD1KMT2ADPP4DPP8DPP9
SCHEMBL31376470 1.00 NOD1 (0.54) NOD1KMT2ADPP4DPP8DPP9
SCHEMBL29630634 0.97 NOD1 (0.52) NOD1KMT2ADPP4DPP8DPP9
Alanyl Glutamine SCHEMBL133886 0.94 NOD1 (0.59) NOD1KMT2ADPP4DPP8DPP9
Alanyl Glutamine SCHEMBL8427100 0.94 NOD1 (0.59) NOD1KMT2ADPP4DPP8DPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122031713-A Preparation method and application of linker medicine and antibody-medicine conjugate thereof 乐普生物科技股份有限公司 2026-05-15 CN claimed
EP-4659764-A1 LINKER DRUG, AND PREPARATION METHOD AND USE OF ANTIBODY-DRUG CONJUGATE THEREOF Lepu Biopharma Co., Ltd. (CN) 2025-12-10 EP claimed
WO-2024160176-A1 LINKER DRUG, AND PREPARATION METHOD AND USE OF ANTIBODY-DRUG CONJUGATE THEREOF 上海美雅珂生物技术有限责任公司 2024-08-08 WO claimed
CN-122075733-A Preparation method and application of linker medicine and antibody-medicine conjugate thereof 2026-05-26 CN disclosed
CN-122031713-A Preparation method and application of linker medicine and antibody-medicine conjugate thereof 乐普生物科技股份有限公司 2026-05-15 CN disclosed
EP-4659764-A1 LINKER DRUG, AND PREPARATION METHOD AND USE OF ANTIBODY-DRUG CONJUGATE THEREOF Lepu Biopharma Co., Ltd. (CN) 2025-12-10 EP disclosed
WO-2024160176-A1 LINKER DRUG, AND PREPARATION METHOD AND USE OF ANTIBODY-DRUG CONJUGATE THEREOF 上海美雅珂生物技术有限责任公司 2024-08-08 WO disclosed